Great news was announced earlier this month to start the New Year off strong for the diabetes community! Medicare is allowing coverage of the Omnipod tubeless insulin pump and the new FreeStyle Libre flash glucose monitoring system. And as Diabetes Mine notes, "since CMS typically sets the stage for what private insurers will cover, this is a big win for PWDs (people with diabetes) of all ages!"
The FDA has approved Abbott’s FreeStyle Libre Flash Glucose Monitoring System for adults, a glucose monitoring system that does not require a blood sample for calibration. Continuous glucose monitoring (CGM) systems require a finger stick for calibration approximately 2-4 times a day. The FDA Press Release describes how this flash glucose monitoring system works:
The FreeStyle Libre Flash system reduces the need for fingerstick testing by using a small sensor wire inserted below the skin’s surface that continuously measures and monitors glucose levels. Users can determine glucose levels by waving a dedicated, mobile reader above the sensor wire to determine if glucose levels are too high (hyperglycemia) or too low (hypoglycemia), and how glucose levels are changing.
This new system could be a game changer for people with diabetes, reducing the cost of supplies and the discomfort of performing daily finger sticks, and creating the need for less site changes since the sensor can be used for 10 days. The FreeStyle Libre Flash Glucose Monitoring System should be available by the end of the year. We’re here to answer any questions you may have at 866.779.8512 (phone) or 248.577.9903 (text).